Chemotherapeutic regimes involving alkylating agents, such as methylators and crosslinking nitrogen mustards, represent a major risk factor for acute myeloid leukaemia. A high frequency of microsatellite instability and evidence of MSH2 loss in alkylating chemotherapy-related acute myeloid leukaemia (t-AML) suggests that DNA mismatch repair (MMR) dysfunction may be an initiating event in disease evolution. Subsequent accumulation of secondary genetic changes as a result of DNA MMR loss may ultimately lead to the gross chromosomal abnormalities seen in t-AML. Homologous recombination repair (HRR) maintains chromosomal stability by the repair of DNA double-strand breaks, and is therefore a possible target for deregulation in MMR dysfunctional...
Methylating agents are widely used in chemotherapy and kill cancer cells by causing DNA dama...
Rearrangements of the Mixed-Lineage Leukemia (MLL) gene are found in 70 % of infant leukemia, 10 ...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
DNA mismatch repair (MMR) defects occur in both sporadic and familial cancers and are associated wit...
The DNA mismatch repair (MMR) pathway is responsible for correction of replicative errors, hence is ...
The phenomenon of alkylation tolerance has been observed in cells that are deficient in some compone...
The complex chromosomal aberrations found in therapy related acute myeloid leukemia (t-AML) suggest ...
The DNA mismatch repair (MMR) pathway, a crucial post-replicative repair pathway, is essential to th...
PhD ThesisThe DNA mismatch repair (MMR) pathway is responsible for correction of replicative errors,...
Thesis (Ph. D. in Genetic Toxicology)--Massachusetts Institute of Technology, Biological Engineering...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Background: Translocations of the Mixed Lineage Leukemia (MLL) gene occur in a subset (5%) of acute ...
DNA-methylating agents of the S(N)2 type target DNA mostly at ring nitrogens, producing predominantl...
Hypomethylating agents (HMA) have become the backbone of nonintensive acute myeloid leukemia/myelody...
Chemotherapy-resistant cancer recurrence is a major cause of mortality. In acute myeloid leukemia (A...
Methylating agents are widely used in chemotherapy and kill cancer cells by causing DNA dama...
Rearrangements of the Mixed-Lineage Leukemia (MLL) gene are found in 70 % of infant leukemia, 10 ...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
DNA mismatch repair (MMR) defects occur in both sporadic and familial cancers and are associated wit...
The DNA mismatch repair (MMR) pathway is responsible for correction of replicative errors, hence is ...
The phenomenon of alkylation tolerance has been observed in cells that are deficient in some compone...
The complex chromosomal aberrations found in therapy related acute myeloid leukemia (t-AML) suggest ...
The DNA mismatch repair (MMR) pathway, a crucial post-replicative repair pathway, is essential to th...
PhD ThesisThe DNA mismatch repair (MMR) pathway is responsible for correction of replicative errors,...
Thesis (Ph. D. in Genetic Toxicology)--Massachusetts Institute of Technology, Biological Engineering...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Background: Translocations of the Mixed Lineage Leukemia (MLL) gene occur in a subset (5%) of acute ...
DNA-methylating agents of the S(N)2 type target DNA mostly at ring nitrogens, producing predominantl...
Hypomethylating agents (HMA) have become the backbone of nonintensive acute myeloid leukemia/myelody...
Chemotherapy-resistant cancer recurrence is a major cause of mortality. In acute myeloid leukemia (A...
Methylating agents are widely used in chemotherapy and kill cancer cells by causing DNA dama...
Rearrangements of the Mixed-Lineage Leukemia (MLL) gene are found in 70 % of infant leukemia, 10 ...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...